INIS
receptors
100%
polypeptides
100%
glucose
100%
nervous system diseases
36%
diseases
18%
modifications
18%
modulation
18%
applications
9%
brain
9%
pancreas
9%
hormones
9%
reviews
9%
regeneration
9%
growth
9%
viability
9%
peptides
9%
neurons
9%
capacity
9%
injuries
9%
central nervous system
9%
glucagon
9%
nervous system
9%
plasticity
9%
Neuroscience
Gastric Inhibitory Polypeptide
100%
Neurodegenerative Disorder
100%
Gastric Inhibitory Polypeptide Receptor
100%
Receptor
46%
Receptor Agonists
23%
Parkinson's Disease
15%
Alzheimer's Disease
15%
Neurodegeneration
15%
Cerebrovascular Disease
15%
Neuroprotection
7%
Glucagon-Like Peptide-1
7%
Incretin
7%
Central Nervous System
7%
Synaptic Plasticity
7%
Nervous System
7%
Neuromodulation
7%
Neurotrauma
7%
Traumatic Brain Injury
7%
Endocrine Pancreas
7%
Neurogenesis
7%
Synaptic Transmission
7%
Medicine and Dentistry
Receptor
100%
Neurodegenerative Disorder
100%
Gastric Inhibitory Polypeptide
100%
Disease
13%
Alzheimer's Disease
13%
Cerebrovascular Disease
13%
Neurodegeneration
13%
Parkinson's Disease
13%
Glucagon Like Peptide 1
6%
Endocrine Pancreas
6%
Neurogenesis
6%
Sequela
6%
Nerve Regeneration
6%
Neuroinflammation
6%
Neuroprotection
6%
Central Nervous System
6%
Traumatic Brain Injury
6%
Synaptic Transmission
6%
Receptor Mediated Signaling
6%
Incretin
6%
Nerve Cell Plasticity
6%
Pleiotropy
6%
Neuromodulation
6%
Neurological System
6%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Disease
100%
Gastric Inhibitory Polypeptide Receptor
100%
Receptor
46%
Receptor Agonist
23%
Nerve Degeneration
15%
Parkinson's Disease
15%
Alzheimer's Disease
15%
Cerebrovascular Disease
15%
Neuroprotection
7%
Nervous System Inflammation
7%
Glucagon-Like Peptide-1
7%
Incretin
7%
Traumatic Brain Injury
7%